|
Exhibit 2.1
EXECUTION COPY
AGREEMENT AND PLAN OF MERGER
BY AND AMONG
ADVANCED MEDICAL OPTICS, INC.
IRONMAN MERGER CORPORATION
and
INTRALASE CORP.
Dated as of January 5, 2007
TABLE OF
CONTENTS
| |
|
|
|
|
|
|
|
|
|
Page
|
|
|
|
1
|
|
|
|
The Merger
|
|
1
|
|
|
|
Effective Time
|
|
2
|
|
|
|
Effect of the Merger
|
|
2
|
|
|
|
Certificate of Incorporation of the Surviving
Corporation
|
|
2
|
|
|
|
Bylaws of the Surviving Corporation
|
|
2
|
|
|
|
Directors and Officers of the Surviving
Corporation
|
|
2
|
|
|
|
Closing
|
|
3
|
|
|
|
3
|
|
|
|
Conversion of Capital Stock
|
|
3
|
|
|
|
Exchange of Certificates
|
|
6
|
|
|
|
Material Adverse Effect
|
|
8
|
|
|
|
9
|
|
|
|
Organization and Qualification;
Subsidiaries
|
|
9
|
|
|
|
Certificate of Incorporation and
Bylaws
|
|
9
|
|
|
|
Capitalization
|
|
10
|
|
|
|
Authority Relative to this Agreement; Stockholder
Approval
|
|
12
|
|
|
|
No Conflict; Required Filings and
Consents
|
|
13
|
|
|
|
Compliance; Permits
|
|
14
|
|
|
|
SEC Filings; Financial Statements
|
|
14
|
|
|
|
Disclosure Controls and Procedures
|
|
15
|
|
|
|
Absence of Certain Changes or Events
|
|
16
|
|
|
|
No Undisclosed Liabilities
|
|
16
|
|
|
|
Absence of Litigation; Investigations
|
|
17
|
|
|
|
Agreements, Contracts and Commitments
|
|
17
|
|
|
|
Employee Benefit Plans, Options and Employment
Agreements
|
|
18
|
|
|
|
Labor Matters
|
|
21
|
|
|
|
Properties; Encumbrances
|
|
23
|
|
|
|
Taxes
|
|
25
|
|
|
|
Environmental Matters
|
|
26
|
|
|
|
Intellectual Property
|
|
28
|
|
|
|
Products
|
|
32
|
|
|
|
FDA Compliance
|
|
33
|
|
|
|
Unlawful Practice of Medicine
|
|
34
|
|
|
|
Compliance with Health Care Laws
|
|
34
|
|
|
|
Brokers
|
|
34
|
|
|
|
Anti-Takeover Statute Not Applicable
|
|
35
|
|
|
|
Insurance
|
|
35
|
|
|
|
Interested Party Transactions
|
|
35
|
|
|
|
Opinion of Financial Advisor of the
Company
|
|
35
|
(i)
| |
|
|
|
|
|
|
|
|
|
Page
|
|
|
|
35
|
|
|
|
Organization and Qualification; Merger
Sub
|
|
35
|
|
|
|
Authority Relative to this Agreement; Stockholder
Approval
|
|
36
|
|
|
|
No Conflict, Required Filings and
Consents
|
|
36
|
|
|
|
Ownership of Company Common Stock
|
|
37
|
|
|
|
Brokers
|
|
37
|
|
|
|
Financing
|
|
37
|
|
|
|
38
|
|
|
|
Conduct of Business by the Company Pending the
Merger
|
|
38
|
|
|
|
Conduct of Business by Parent Pending the
Merger
|
|
41
|
|
|
|
42
|
|
|
|
Access to Information; Confidentiality
|
|
42
|
|
|
|
No Solicitation
|
|
42
|
|
|
|
Proxy Statement
|
|
45
|
|
|
|
Stockholders Meeting
|
|
46
|
|
|
|
Legal Conditions to Merger
|
|
47
|
|
|
|
Public Announcements
|
|
48
|
|
|
|
Employee Benefits; 401(k) Plan
|
|
49
|
|
|
|
2004 Employee Stock Plan
|
|
49
|
|
|
|
Consents
|
|
50
|
|
|
|
Indemnification and Insurance
|
|
50
|
|
|
|
Reasonable Best Efforts; Additional
Agreements
|
|
50
|
|
|
|
Notification of Certain Matters
|
|
51
|
|
|
|
Takeover Statutes
|
|
52
|
|
|
|
Current Information
|
|
52
|
|
|
|
Stock Delisting
|
|
52
|
|
|
|
52
|
|
|
|
Conditions to Obligation of Each Party to Effect
the Merger
|
|
52
|
|
|
|
Additional Conditions to Obligations of Parent
and Merger Sub
|
|
53
|
|
|
|
Additional Conditions to Obligation of the
Company
|
|
54
|
|
|
|
54
|
|
|
|
Termination
|
|
55
|
|
|
|
Effect of Termination
|
|
56
|
|
|
|
Fees and Expenses
|
|
56
|
|
|
|
57
|
|
|
|
Nonsurvival of Representations; Warranties and
Agreements
|
|
57
|
|
|
|
Notices
|
|
58
|
|
|
|
Certain Definitions
|
|
59
|
|
|
|
Amendment
|
|
60
|
|
|
|
Extension; Waiver
|
|
60
|
|
|
|
Headings
|
|
61
|
|
|
|
Severability
|
|
61
|
|
|
|
Entire Agreement; No Third Party
Beneficiaries
|
|
61
|
|
|
|
Assignment
|
|
61
|
(ii)
| |
|
|
|
|
|
|
|
|
|
Page
|
|
|
|
Failure or Indulgence Not Waiver; Remedies
Cumulative
|
|
61
|
|
|
|
Governing Law
|
|
62
|
|
|
|
Counterparts
|
|
62
|
|
|
|
WAIVER OF JURY TRIAL
|
|
62
|
|
|
|
Specific Performance
|
|
62
|
|
|
|
Disclosure Schedules
|
|
62
|
DEFINED
TERMS
| |
|
|
|
|
|
Page
|
|
|
|
10
|
|
|
|
10
|
|
|
|
10
|
|
|
|
49
|
|
|
|
44
|
|
|
|
58
|
|
|
|
1
|
|
|
|
11
|
|
|
|
58
|
|
|
|
16
|
|
|
|
59
|
|
|
|
59
|
|
|
|
2
|
|
|
|
6
|
|
|
|
44
|
|
|
|
3
|
|
|
|
3
|
|
|
|
1
|
|
|
|
1, 12
|
|
|
|
9
|
|
|
|
9
|
|
|
|
1, 3
|
|
|
|
9
|
|
|
|
18
|
|
|
|
48
|
|
|
|
28
|
|
|
|
8
|
|
|
|
5, 10
|
|
|
|
10
|
|
|
|
42
|
|
|
|
59
|
|
|
|
49
|
|
|
|
1
|
|
|
|
4
|
(iii)
| |
|
|
|
|
|
13
|
|
|
|
2
|
|
|
|
18
|
|
|
|
27
|
|
|
|
18
|
|
|
|
18
|
|
|
|
12
|
|
|
|
55
|
|
|
|
14
|
|
|
|
14
|
|
|
|
17
|
|
|
|
6
|
|
|
|
15
|
|
|
|
13
|
|
|
|
34
|
|
|
|
13
|
|
|
|
28
|
|
|
|
59
|
|
|
|
49
|
|
|
|
3
|
|
|
|
59
|
|
|
|
29
|
|
|
|
30
|
|
|
|
59
|
|
|
|
59
|
|
|
|
24
|
|
|
|
12
|
|
|
|
28
|
|
|
|
17
|
|
|
|
26
|
|
|
|
1
|
|
|
|
3
|
|
|
|
1
|
|
|
|
2
|
|
|
|
2
|
|
|
|
4
|
|
|
|
36
|
|
|
|
28
|
|
|
|
54
|
|
|
|
24
|
|
|
|
1
|
|
|
|
36
|
|
|
|
36
|
|
|
|
35
|
|
|
|
8
|
(iv)
| |
|
|
|
|
|
36
|
|
|
|
6
|
|
|
|
14
|
|
|
|
59
|
|
|
|
10
|
|
|
|
10
|
|
|
|
34
|
|
|
|
31
|
|
|
|
45
|
|
|
|
19
|
|
|
|
24
|
|
|
|
15
|
|
|
|
13
|
|
|
|
14
|
|
|
|
42
|
|
|
|
12
|
|
|
|
4
|
|
|
|
10
|
|
|
|
45
|
|
|
|
1
|
|
|
|
34
|
|
|
|
25
|
|
|
|
25
|
|
|
|
25
|
|
|
|
56
|
|
|
|
1
|
|
|
|
12
|
|
|
|
23
|
(v)
AGREEMENT AND PLAN OF
MERGER
AGREEMENT AND PLAN OF MERGER, dated as of January 5, 2007
(this " Agreement "), by and among Advanced Medical Optics,
Inc., a Delaware corporation (" Parent "), Ironman Merger
Corporation, a Delaware corporation and a wholly owned subsidiary
of Parent (" Merger Sub "), and IntraLase Corp., a Delaware
corporation (the " Company ").
WHEREAS, the respective Boards of Directors of each of Parent,
Merger Sub and the Company have (i) approved and declared
advisable and in the best interests of their respective
stockholders the merger of Merger Sub with and into the Company
(the " Merger "), upon the terms and subject to the
conditions set forth in this Agreement and the General Corporation
Law of the State of Delaware (the " DGCL ") and
(ii) approved this Agreement;
WHEREAS, as a result of the Merger, and in accordance with the
DGCL, each issued and outstanding share of common stock, par value
$0.01 per share, of the Company (the " Company Common Stock
") (other than shares of Company Common Stock owned by the Company,
Parent, Merger Sub or any wholly-owned Subsidiary (as defined in
Section 2.1(b)) of the Company or Parent immediately prior to
the Effective Time (as defined in Section 1.2) and Dissenting
Shares (as defined in Section 2.1(d)), will, upon the terms
and subject to the conditions set forth herein, be converted into
the right to receive the Merger Consideration (as defined in
Section 2.1(a)); and
WHEREAS, as a condition and inducement to Parent to enter into
this Agreement and incur the obligations set forth herein,
concurrently with the execution and delivery of this Agreement,
Parent is entering into Voting Agreements with certain stockholders
of the Company named therein, substantially in the form of Exhibit
A attached to this Agreement (the " Voting Agreements "),
pursuant to which, among other things, such stockholders have
agreed to vote the shares of Company Common Stock held by such
stockholders in favor of the adoption of this Agreement and the
approval of the Merger provided for herein, on the terms and
subject to the conditions set forth in the Voting Agreements.
NOW, THEREFORE, in consideration of the foregoing and the
respective representations, warranties, covenants and agreements
set forth below, the parties hereto agree as follows:
ARTICLE I
THE MERGER
Section 1.1 The Merger. Subject to the terms and
conditions of this Agreement and in accordance with the DGCL, at
the Effective Time, Merger Sub shall merge with and into the
Company, the separate corporate existence of Merger Sub shall cease
and the Company shall continue as the surviving corporation in the
Merger. The Company, in its capacity as the corporation surviving
the Merger, is hereinafter sometimes referred to as the "
Surviving Corporation ."
Section 1.2 Effective Time . On the
Closing Date (as defined in Section 1.7), Parent and the
Company shall cause the Merger to be consummated by filing a duly
executed and delivered certificate of merger as required by the
DGCL (the " Certificate of Merger ") with the Secretary of
State of the State of Delaware, in such form as required by, and
executed in accordance with the relevant provisions of the DGCL
(the time of such filing, or such other time as Parent and the
Company shall specify in the Certificate of Merger, being the "
Effective Time ").
Section 1.3 Effect of the Merger . At the Effective
Time, the effect of the Merger shall be as provided in this
Agreement and the Certificate of Merger and as specified in the
DGCL (including Section 259 of the DGCL). Without limiting the
generality of the foregoing, and subject thereto, at the Effective
Time, all the property, rights, privileges, powers and franchises
of the Company and Merger Sub shall vest in the Surviving
Corporation, and all debts, liabilities, obligations, restrictions,
disabilities and duties of each of the Company and the Merger Sub
shall become the debts, liabilities, obligations, restrictions,
disabilities and duties of the Surviving Corporation.
Section 1.4 Certificate of Incorporation of the
Surviving Corporation . At and after the Effective Time, the
Certificate of Incorporation of Merger Sub (the " Merger Sub
Charter "), as in effect immediately prior to the Effective
Time, subject to the provisions of Section 6.10, shall be the
Certificate of Incorporation of the Surviving Corporation, until
amended in accordance with the DGCL, except that the name of the
Surviving Corporation shall be "IntraLase Corp."
Section 1.5 Bylaws of the Surviving Corporation . At
and after the Effective Time, the Bylaws of Merger Sub (the "
Merger Sub Bylaws "), as in effect immediately prior to the
Effective Time, subject to the provisions of Section 6.10,
shall be the Bylaws of Surviving Corporation, until amended in
accordance with the DGCL, except that the name of the Surviving
Corporation shall be "IntraLase Corp."
Section 1.6 Directors and Officers of the Surviving
Corporation .
(a) The directors of Merger Sub immediately prior to the
Effective Time shall be the initial directors of the Surviving
Corporation and shall hold office from the Effective Time until
their respective successors are duly elected or appointed and
qualified in the manner provided in the Certificate of
Incorporation or Bylaws of the Surviving Corporation or as
otherwise provided by Law.
(b) The officers of Merger Sub immediately prior to the
Effective Time shall be the initial officers of the Surviving
Corporation and shall hold office from the Effective Time until
their respective successors are duly elected or appointed and
qualified in the manner provided in the Certificate of
Incorporation or Bylaws of the Surviving Corporation or as
otherwise provided by Law.
2
Section 1.7 Closing . Subject to the
provisions of this Agreement, the closing of the Merger (the "
Closing ") shall take place at 10:00 a.m. Los Angeles Time,
at the offices of Skadden, Arps, Slate, Meagher & Flom
LLP, 300 South Grand Avenue, Los Angeles, California on a date to
be specified by Parent and the Company which shall be no later than
the third (3 rd ) business day after satisfaction or waiver of each of the
conditions set forth in Article VII (other than the delivery of
items to be delivered at Closing and other than those conditions
that by their nature are to be satisfied at the Closing, it being
understood that the occurrence of the Closing shall remain subject
to the delivery of such items and the satisfaction or waiver of
such conditions at the Closing) (the " Initial Closing Date
") or on such other date and such other time and place as Parent
and the Company shall agree in writing. Notwithstanding the
foregoing, at its election, Parent may delay the Closing for up to
twenty (20) days after the Initial Closing Date, but in no
event may Parent delay the Closing beyond the Outside Date. Such
election shall operate as an irrevocable waiver of the conditions
set forth in Section 7.2 hereof and shall be accompanied by
the officers’ certifications referred to in
Section 7.3(a) and 7.3(b) hereof (other than with respect to
the payment of the Merger Consideration), provided that the Company
has delivered to Parent at or prior to the time of such election,
the officers’ certifications referred to in
Section 7.2(a) and 7.2(b) hereof dated as of the Initial
Closing Date. The date on which the Closing shall occur is
hereinafter referred to as the " Closing Date ."
ARTICLE II
CONVERSION AND EXCHANGE OF SECURITIES
Section 2.1 Conversion of Capital Stock . At the
Effective Time, by virtue of the Merger and without any action on
the part of the Company, Parent, Merger Sub or any holder of any
shares of Company Common Stock or any capital stock of Merger
Sub:
(a) Company Common Stock . Subject to this Article II,
each share of Company Common Stock issued and outstanding
immediately prior to the Effective Time (other than any Dissenting
Shares (as defined in Section 2.1(d)(i)) and any shares to be
cancelled in accordance with Section 2.1(b)), shall be
converted into the right to receive $25.00 in cash without interest
(the " Merger Consideration "), payable upon the surrender
of the Certificates (as defined in Section 2.2(b)). From and
after the Effective Time, all such shares of Company Common Stock,
shall no longer be outstanding and shall automatically be cancelled
and retired and shall cease to exist, and each holder of a
Certificate representing any such shares shall cease to have any
rights with respect thereto, except the right to receive the Merger
Consideration pursuant to this Section 2.1(a). Notwithstanding
the foregoing, the Merger Consideration shall be appropriately
adjusted to reflect fully the effect of any stock split, reverse
split, reclassification, stock dividend, reorganization,
recapitalization, consolidation, exchange or other like change with
respect to the Company Common Stock occurring (or having a record
date) after the date of this Agreement and prior to the Effective
Time;
(b) Cancellation of Treasury Stock and Parent-Owned Stock
. All shares of Company Common Stock, that are (i) held by the
Company as treasury shares or
3
(ii) owned by Parent or any wholly owned
Subsidiary (as defined below) of Parent, in each case immediately
prior to the Effective Time, shall be cancelled and retired and
shall cease to exist, and no securities of Parent or other
consideration shall be delivered in exchange therefor. As used in
this Agreement, the word " Subsidiary " means, with respect
to any party, any corporation or other organization, whether
incorporated or unincorporated, of which (A) such party or any
other Subsidiary of such party is a general partner, manager or
managing member, (B) such party or any Subsidiary of such
party owns in excess of a majority of the outstanding equity or
voting securities or interests or (C) such party or any
Subsidiary of such party has the right to elect at least a majority
of the board of directors or others performing similar functions
with respect to such corporation or other organization;
and
(c) Capital Stock of Merger Sub . Each share of common
stock, par value $0.01 per share, of Merger Sub (" Merger Sub
Common Stock ") issued and outstanding immediately prior to the
Effective Time shall be converted into and become one fully paid
and nonassessable share of common stock, par value $0.01 per share,
of the Surviving Corporation and such shares of common stock issued
upon conversion of the Merger Sub Common Stock shall represent all
of the outstanding shares of the Surviving Corporation.
(d) Shares of Company Common Stock of Dissenting
Stockholders .
-
(i) Notwithstanding any provision of this Agreement to the
contrary, all of the shares of Company Common Stock that are
outstanding immediately prior to the Effective Time and which are
held by holders of Company Common Stock who shall not have voted in
favor of the Merger or consented thereto in writing and who shall
have demanded properly in writing an appraisal of the "fair value"
of such Company Common Stock in accordance with Section 262 of
the DGCL (collectively, the " Dissenting Shares ") shall be
cancelled and terminated and shall cease to have any rights with
respect to Dissenting Shares other than such rights as are granted
pursuant to Section 262 of the DGCL, except that all
Dissenting Shares held by holders of Company Common Stock who shall
have failed to perfect or who effectively shall have withdrawn or
lost their rights for an appraisal of such shares under the DGCL
shall thereupon be deemed to have been cancelled and terminated, as
of the Effective Time, and shall represent solely the right to
receive the Merger Consideration as provided in
Section 2.1(a), upon surrender in the manner provided in
Section 2.2(b), of the certificate or certificates that
formerly evidenced such shares of Company Common Stock.
(ii) The Company shall give to Parent prompt written notice of
any demands for appraisal received by the Company, withdrawals of
such demands, and any other instruments served pursuant to
Section 262 of the DGCL and received by the Company in
connection therewith. The Company and Parent shall jointly direct
all negotiations and proceedings with respect to demands for
payment of fair market value under
4
-
the DGCL. The Company shall not, except with the
prior written consent of Parent, voluntarily make any payment with
respect to any such demands, or offer to settle, or settle, any
such demands. Any amount payable to any holder of Company Common
Stock exercising appraisal rights shall be paid in accordance with
the DGCL solely by the Surviving Corporation out of its own
funds.
(e) Stock Options .
-
(i) At the Effective Time, each outstanding option entitling the
holder thereof to purchase shares of Company Common Stock pursuant
to the Company Stock Plans, other than the 2004 Employee Plan
(each, a " Company Stock Option " or collectively "
Company Stock Options "), to the extent not already fully
vested and exercisable, shall become fully vested and exercisable
immediately prior to consummation of the Merger, but excluding any
Company Stock Options held or beneficially owned by Parent or
Merger Sub or any other Subsidiary or parent of Parent or Merger
Sub, and shall be converted into and shall become the right to
receive, in full and complete satisfaction and cancellation
thereof, a cash payment per Company Stock Option, without interest,
in an amount that shall be determined by multiplying (A) the
excess, if any, of the Merger Consideration over the applicable per
share exercise price of such Company Stock Option, by (B) the
number of shares of Company Common Stock that are purchasable on
exercise of such Company Stock Option prior to the Effective Time
but subsequent to any acceleration of vesting provided for in this
Section 2.1(e)(i), less any mandatory tax withholdings (the "
Option Payment "). At the Effective Time, all outstanding
Company Stock Options (including any Company Stock Option for which
no payment shall be due hereunder) shall be canceled and be of no
further force or effect except for the right to receive the cash
Option Payment to the extent provided in this Section 2.1(e).
Prior to the Effective Time, the Company and Parent shall take all
actions (including, if appropriate, amending the terms of the
Company Stock Plans and related option agreements) that are
necessary to give effect to the transactions contemplated by this
Section 2.1(e).
(ii) Prior to the Effective Time, Parent and the Company shall
establish a procedure to effect the cancellation of Company Stock
Options in exchange for the Option Payments to which the holders of
such Company Stock Options shall be entitled under
Section 2.1(e)(i), and, upon cancellation of each such Company
Stock Option, Parent shall pay to the holder thereof in cash
promptly after Closing but in no event more than ten
(10) business days after Closing, the amount of the Option
Payment, if any, to which such holder shall be entitled hereunder,
without further action on the part of such holder.
5
-
(iii) Parent, Merger Sub and the Company hereby
acknowledge and agree that the Surviving Corporation shall not
assume or continue any Company Stock Options, or substitute any
additional options for such Company Stock Options.
Section 2.2 Exchange of Certificates .
(a) Paying Agent . Prior to the Closing Date, Parent
shall designate a bank or trust company reasonably acceptable to
the Company to act as Paying Agent hereunder (the " Paying
Agent "). As soon as practicable after the Effective Time,
Parent shall deposit with or for the account of the Paying Agent,
for the benefit of the holders of Company Common Stock, an amount
of cash sufficient to deliver to the holders of Company Common
Stock the Merger Consideration (such cash, being hereinafter
referred to as the " Fund ") deliverable pursuant to
Section 2.1(a) in exchange for outstanding shares of Company
Common Stock. The Paying Agent shall invest the cash included in
the Fund in obligations guaranteed by the full faith and credit of
the United States of America. All interest earned on such funds
shall be paid to Parent.
(b) Exchange Procedures . As soon as reasonably
practicable after the Effective Time and in no event later than
five (5) days thereafter, Parent will instruct the Paying
Agent to mail to each holder of record of a certificate or
certificates which immediately prior to the Effective Time
represented outstanding shares of Company Common Stock (the "
Certificates ") that were converted pursuant to
Section 2.1(a) into the right to receive the Merger
Consideration (i) a letter of transmittal (which shall specify
that delivery shall be effected, and risk of loss and title to the
Certificates shall pass, only upon proper delivery of the
Certificates to the Paying Agent and shall be in such form and have
such other provisions as Parent may reasonably specify that are
consistent with the terms of this Agreement), and
(ii) instructions for use in effecting the surrender of the
Certificates in exchange for the Merger Consideration. Upon
surrender of a Certificate for cancellation to the Paying Agent
together with such letter of transmittal, duly executed, and such
other customary documents as may be required pursuant to such
instructions, the holder of such Certificate shall be entitled to
receive in exchange therefor the Merger Consideration, after giving
effect to any tax withholdings required by applicable Law, and the
Certificate so surrendered shall forthwith be cancelled. In the
event of a transfer of ownership of Company Common Stock that is
not registered in the transfer records of the Company, payment may
be made to a person other than the person in whose name the
Certificate so surrendered is registered, if such Certificate shall
be properly endorsed or otherwise be in proper form for transfer
and the person requesting such payment shall pay any transfer or
other taxes required by reason of the payment to a person other
than the registered holder of such Certificate or establish to the
reasonable satisfaction of the Surviving Corporation that such tax
has been paid or is not applicable. Until so surrendered, each
outstanding Certificate that, prior to the Effective Time,
represented shares of Company Common Stock will be deemed, from and
after the Effective Time, for all corporate purposes, to represent
only the right to receive upon surrender the Merger Consideration,
in accordance with the terms of this Agreement.
6
(c) Termination of Fund; No Liability . At
any time following the first anniversary of the Effective Time,
Parent shall be entitled to require the Paying Agent to deliver to
Parent any portion of the Fund (including any interest received
with respect thereto) not disbursed to holders of Certificates, and
thereafter such holders shall be entitled to look only to Parent
(subject to abandoned property, escheat or other similar Law) with
respect to the Merger Consideration upon due surrender of their
Certificates, without any interest thereon. Neither Parent, Merger
Sub nor the Company shall be liable to any holder of Company Common
Stock, for such shares (or dividends or distributions with respect
thereto) delivered to a public official pursuant to any applicable
abandoned property, escheat or other similar Law following the
passage of time specified therein. If any Certificates shall not
have been surrendered immediately prior to such date on which any
payment pursuant to this Article II would otherwise escheat to or
become the property of any Governmental Authority, the Merger
Consideration in respect of such Certificate shall, to the extent
permitted by applicable law, become the property of Parent, free
and clear of all claims or interests of any person previously
entitled thereto.
(d) Withholding Rights . Parent, the Surviving
Corporation or the Paying Agent shall be entitled to deduct and
withhold from the Merger Consideration otherwise payable pursuant
to this Agreement to any person who was a holder of Company Common
Stock immediately prior to the Effective Time such amounts as
Parent or the Paying Agent is required to deduct and withhold with
respect to the making of such payment under the Code, or any
provision of state, local or foreign tax Law. To the extent that
amounts are so withheld by Parent, the Surviving Corporation or the
Paying Agent, such withheld amounts shall be treated for all
purposes of this Agreement as having been paid to the holder of the
shares of Company Common Stock in respect of which such deduction
and withholding was made by Parent, the Surviving Corporation or
the Paying Agent.
(e) No Further Ownership Rights in Company Stock . At the
Effective Time, the stock transfer books of the Company shall be
closed and thereafter there shall be no further registration of
transfers on the stock transfer books of the Company or the
Surviving Corporation of the shares of Company Common Stock which
were outstanding immediately prior to such time. If, after such
time, Certificates are presented to the Surviving Corporation for
any reason, they shall be cancelled and exchanged as provided in
this Article II.
(f) Lost, Stolen or Destroyed Certificates . In the event
any Certificates shall have been lost, stolen or destroyed, the
Paying Agent shall issue in exchange for such lost, stolen or
destroyed Certificates, upon the making of an affidavit of that
fact by the holder thereof, such Merger Consideration as provided
in this Article II; provided , however , that Parent
may, in its discretion and as a condition precedent thereof,
require the owner of such lost, stolen or destroyed Certificates to
deliver an agreement of indemnification in form satisfactory to
Parent, or a bond in such sum as Parent may reasonably direct as
indemnity against any claim that may be made against Parent or the
Paying Agent with respect to the Certificates alleged to have been
lost, stolen or destroyed.
7
Section 2.3 Material Adverse Effect
.
(a) The term " Company Material Adverse Effect " means
any change, effect or circumstance that (i) is materially
adverse to the business, condition (financial or otherwise),
operations, performance, properties or prospects of the Company and
its Subsidiaries, taken as a whole, or (ii) materially
adversely affects the consummation of the transactions contemplated
hereby; provided, however, that in no event shall any of the
following, either alone or in combination, be deemed to constitute,
nor shall any of the following be taken into account in determining
whether there has been or will or could be, a Company Material
Adverse Effect: (A) any changes resulting from or arising out
of general market, economic or political conditions (including any
changes arising out of acts of terrorism, or war, weather
conditions or other force majeure events), provided that such
changes do not have a substantially disproportionate impact on the
Company and its Subsidiaries, taken as a whole, (B) any
changes resulting from or arising out of general market, economic
or political conditions in the industries in which the Company or
any of its Subsidiaries conduct business (including any changes
arising out of acts of terrorism, or war, weather conditions or
other force majeure events), provided that such changes do not have
a substantially disproportionate impact on the Company and its
Subsidiaries, taken as a whole, (C) any changes resulting from
or arising out of actions taken pursuant to (and required by) this
Agreement or at the request of Parent or the failure to take any
actions due to restrictions set forth in this Agreement,
(D) any changes in the price or trading volume of the
Company’s stock, in and of itself, (E) any failure by
the Company to meet published revenue or earnings projections, in
and of itself, (F) any changes or effects arising out of or
resulting from any legal claims or other proceedings made by any of
the Company’s stockholders arising out of or related to this
Agreement or the Merger, or (G) any changes arising out of or
resulting from any delay with respect to the receipt by the Company
or any of its Subsidiaries of pending regulatory approvals relating
to its proposed product offerings of no longer than three months
after the date that the Company has informed Parent it expects to
obtain such pending regulatory approvals (provided that at all
times during such period, such approvals are still pending and can
be reasonably expected to be obtained within such period).
(b) The term " Parent Material Adverse Effect " means any
change, effect or circumstance that materially adversely affects
the consummation of the transactions contemplated hereby; provided,
however, that in no event shall any of the following, either alone
or in combination, be deemed to constitute, nor shall any of the
following be taken into account in determining whether there has
been or will or could be, a Parent Material Adverse Effect:
(A) any changes resulting from or arising out of general
market, economic or political conditions (including any changes
arising out of acts of terrorism, or war, weather conditions or
other force majeure events), provided that such changes do not have
a substantially disproportionate impact on Parent and its
Subsidiaries, taken as a whole, (B) any changes resulting from
or arising out of general market, economic or political conditions
in the industries in which Parent or any of its Subsidiaries
conduct business (including any changes arising out of acts of
terrorism, or war, weather conditions or other force majeure
events), provided that such changes do not have a substantially
disproportionate impact on Parent and its Subsidiaries, taken as a
whole, (C) any changes resulting from or arising out of
actions taken pursuant to (and required by) this Agreement or
8
at the request of the Company or the failure to
take any actions due to restrictions set forth in this Agreement,
(D) any changes in the price or trading volume of
Parent’s stock, in and of itself, (E) any changes or
effects arising out of or resulting from any legal claims or other
proceedings made by any of Parent’s stockholders arising out
of or related to this Agreement or the Merger, or (F) any
failure by Parent to meet published revenue or earnings
projections, in and of itself.
ARTICLE III
REPRESENTATIONS AND WARRANTIES
Except as specifically set forth in the written disclosure
schedule prepared by the Company which is dated as of the date of
this Agreement and was previously delivered by the Company to
Parent in connection herewith (the " Company Disclosure
Schedule "), the Company represents and warrants to Parent and
Merger Sub as follows:
Section 3.1 Organization and Qualification;
Subsidiaries . The Company and each of its Subsidiaries is an
entity duly organized, validly existing and in good standing under
the Laws of the jurisdiction of its incorporation and has the
requisite corporate power and authority necessary to own, lease and
operate the properties it purports to own, lease or operate and to
carry on its business as it is now being conducted. Each of the
Company and each of its Subsidiaries is duly qualified or licensed
as a foreign corporation to do business, and is in good standing,
in each jurisdiction where the character or location of the
properties owned, leased or operated by it or the nature of its
activities makes such qualification or licensing necessary, except
for such failures to be so qualified or licensed and in good
standing that would not reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse
Effect. A true, complete and correct list of all of the
Company’s Subsidiaries, together with the jurisdiction of
incorporation of each Subsidiary, the authorized capitalization of
each Subsidiary, and the percentage of each Subsidiary’s
outstanding capital stock owned by the Company or another
Subsidiary or affiliate of the Company, is set forth in
Section 3.1 of the Company Disclosure Schedule. Except as set
forth in Section 3.1 of the Company Disclosure Schedule, the
Company does not directly or indirectly own any equity or similar
interest in, or any interest convertible into or exchangeable or
exercisable for any equity or similar interest in, any corporation,
partnership, limited liability company, joint venture or other
business association or entity, excluding securities in any
publicly traded company held for investment by the Company and
comprising less than one percent of the outstanding stock of such
publicly traded company.
Section 3.2 Certificate of Incorporation and Bylaws
. The Company has heretofore made available to Parent a true,
complete and correct copy of its Seventh Amended and Restated
Certificate of Incorporation, as amended to date (the " Company
Charter "), and Second Amended and Restated Bylaws, as amended
to date (the " Company Bylaws "), and has furnished to
Parent true, complete and correct copies of the charter and bylaws
(or equivalent organizational documents), each as amended to date,
of each of its Subsidiaries (the " Subsidiary Documents ").
The Company Charter, Company Bylaws and
9
the Subsidiary Documents are in full force and
effect. The Company is not in violation of any of the provisions of
the Company Charter or Company Bylaws and the Company’s
Subsidiaries are not in violation of any of the provisions of their
respective Subsidiary Documents.
Section 3.3 Capitalization .
(a) The authorized capital stock of the Company consists of
45,000,000 shares of Company Common Stock and 10,000,000 shares of
preferred stock (the " Preferred Stock "). As of
December 31, 2006, (i) 28,888,487 shares of Company
Common Stock are issued and outstanding; (ii) 86,151 shares of
Company Common Stock are reserved for issuance upon exercise of
awards granted pursuant to the Company’s Amended and Restated
Stock Option Plan (the " Plan "); (iii) 3,587,257
shares of Company Common Stock are reserved for issuance upon
exercise of awards granted pursuant to the Company’s 2000
Stock Incentive Plan (the " 2000 Incentive Plan ");
(iv) 156,075 shares of Company Common Stock are reserved for
issuance upon exercise of awards granted pursuant to the
Company’s 2000 Executive Option Plan (the " 2000 Option
Plan "); (v) 5,580,027 shares of Company Common Stock are
reserved for issuance upon exercise of awards granted pursuant to
the Company’s Amended and Restated 2004 Stock Incentive Plan
(the " 2004 Incentive Plan "); (vi) 530,812 shares of
the Company Common Stock are reserved for issuance upon exercise of
awards granted pursuant to the Company’s 2004 Employee Stock
Purchase Plan (the " 2004 Employee Plan " and, together with
the Plan, the 2000 Incentive Plan, the 2000 Option Plan and the
2004 Incentive Plan, the " Company Stock Plans ");
(vii) no shares of Company Common Stock are issued and held in
the treasury of the Company; (viii) no shares of Preferred
Stock are issued and outstanding. The Company has not authorized
the issuance of any rights representing a right to purchase shares
of preferred stock and the Company has not entered into a
stockholder rights plan or similar agreement that could have a
dilutive effect on certain stockholders. Between December 31,
2006 and the date of this Agreement, the Company has not issued any
securities (including derivative securities) except for shares of
Company Common Stock issued upon exercise of stock options
outstanding.
(b) Section 3.3(b) of the Company Disclosure Schedule sets
forth a true, complete and correct list of all persons who, as of
December 31, 2006 held outstanding awards to acquire shares of
Company Common Stock (the " Company Stock Options ") under
the Company Stock Plans, indicating, with respect to each Company
Stock Option then outstanding, the type of awards granted, whether
an award was an incentive stock option, the number of shares of
Company Common Stock subject to such Company Stock Option, the
relationship of the holder of such Company Stock Option to the
Company, the name of the plan under which such Company Stock Option
was granted and the exercise price, date of grant, vesting schedule
and expiration date thereof, including the extent to which any
vesting had occurred as of the date of this Agreement and whether
(and to what extent) the vesting of such Company Stock Option will
be accelerated in any way by the consummation of the transactions
contemplated by this Agreement or by the termination of employment
or engagement or change in position of any holder thereof following
or in connection with the consummation of the Merger. The Company
has delivered to Parent true, complete and
10
correct copies of all Company Stock Plans and the
forms of all stock option agreements evidencing outstanding Company
Stock Options. Each grant of Company Stock Options was validly
issued and properly approved by the Board of Directors of the
Company (or a duly authorized committee or subcommittee thereof) in
compliance with all applicable legal requirements and recorded on
the Company’s financial statements in accordance with GAAP
consistently applied, and no such grants involved any "back
dating," "forward dating" or similar practices with respect to the
effective date of grant. Each Company Stock Option that is an
incentive stock option had, on the date of grant, an exercise price
of no less than the fair market value of the shares of Company
Common Stock subject to such Company Stock Option.
(c) Except as described in Section 3.3(a) of this Agreement
or as set forth in Section 3.3(b) of the Company Disclosure
Schedule, no capital stock of the Company or any of its
Subsidiaries or any security convertible or exchangeable into or
exercisable for such capital stock, is issued, reserved for
issuance or outstanding as of the date of this Agreement. Except as
described in Section 3.3(a) of this Agreement or as set forth
in Section 3.3(b) of the Company Disclosure Schedule, there
are no options, preemptive rights, warrants, calls, rights,
commitments, agreements, arrangements or understandings of any kind
to which the Company or any of its Subsidiaries is a party, or by
which the Company or any of its Subsidiaries is bound, obligating
the Company or any of its Subsidiaries to issue, deliver or sell,
or cause to be issued, delivered or sold, additional shares of
capital stock of the Company or any of its Subsidiaries or
obligating the Company or any of its Subsidiaries to grant, extend
or accelerate the vesting of or enter into any such option,
warrant, call, right, commitment, agreement, arrangement or
understanding. There are no stockholder agreements, voting trusts,
proxies or other similar agreements, arrangements or understandings
to which the Company or any of its Subsidiaries is a party, or by
which it or they are bound, obligating the Company or any of its
Subsidiaries with respect to any shares of capital stock of the
Company or any of its Subsidiaries. There are no rights or
obligations, contingent or otherwise (including rights of first
refusal in favor of the Company), of the Company or any of its
Subsidiaries, to repurchase, redeem or otherwise acquire any shares
of capital stock of the Company or any of its Subsidiaries or to
provide funds to or make any investment (in the form of a loan,
capital contribution or otherwise) in any such Subsidiary or any
other entity. There are no registration rights or other similar
agreements, arrangements or understandings to which the Company or
any of its Subsidiaries is a party, or by which it or they are
bound, obligating the Company or any of its Subsidiaries with
respect to any shares of Company Common Stock or shares of capital
stock of any such Subsidiary.
(d) All outstanding shares of the Company’s capital stock
are, and all shares of Company Common Stock reserved for issuance
as specified above shall be, upon issuance on the terms and
conditions specified in the instruments pursuant to which they are
issuable, duly authorized, validly issued, fully paid and
nonassessable and not subject to or issued in violation of any
purchase option, call option, right of first refusal, pre-emptive
right, subscription right or any similar right under any provision
of the DGCL, the Company Charter or the Company Bylaws or any
agreement to which the Company is a party or otherwise bound. None
of the outstanding shares of Company Common Stock have
11
been issued in violation of any federal or state
securities Laws. All of the outstanding shares of capital stock of
each of the Company’s Subsidiaries are duly authorized,
validly issued, fully paid and nonassessable, and all such shares
(other than directors’ qualifying shares in the case of
foreign Subsidiaries) are owned by the Company or a Subsidiary of
the Company free and clear of all security interests, liens,
claims, pledges, agreements, limitations in voting rights, charges
or other encumbrances of any nature whatsoever (collectively, "
Liens "). There are no accrued and unpaid dividends with
respect to any outstanding shares of capital stock of the Company
or any of its Subsidiaries.
(e) The Company Common Stock constitutes the only class of
securities of the Company or its Subsidiaries registered or
required to be registered under the Securities Exchange Act of
1934, as amended (the " Exchange Act ").
Section 3.4 Authority Relative to this Agreement;
Stockholder Approval .
(a) Subject only to the approval of the stockholders of the
Company as described below, the Company has full corporate power
and authority to execute and deliver this Agreement and to
consummate the transactions contemplated hereby. The execution and
delivery of this Agreement and the consummation of the transactions
contemplated hereby have been duly and validly approved by the
Board of Directors of the Company (the " Company Board ").
As of the date of this Agreement, the Company Board has determined
that this Agreement and the transactions contemplated hereby are
advisable and in the best interests of the stockholders of the
Company and has recommended that the stockholders of the Company
adopt this Agreement and approve the Merger (the " Voting
Proposal "). The action taken by the Company Board constitutes
approval of the Merger and the other transactions contemplated
hereby by the Company Board under the provisions of
Section 203 of the DGCL such that Section 203 of the DGCL
does not apply to this Agreement or the transactions contemplated
hereby. This Agreement has been duly and validly executed and
delivered by the Company, and (assuming due authorization,
execution and delivery by Parent and Merger Sub) this Agreement
constitutes a valid and binding obligation of the Company,
enforceable against the Company in accordance with its terms,
except as such enforceability may be limited by bankruptcy,
insolvency, fraudulent conveyance, reorganization, moratorium or
other similar Laws now or hereafter in effect relating to
creditors’ rights generally and by general equitable
principles (regardless of whether enforceability is considered in a
proceeding in equity or at Law).
(b) Except for the approval of the Voting Proposal by the
affirmative vote of the holders of a majority of the outstanding
shares of the Company Common Stock entitled to vote at a meeting of
the stockholders of the Company to consider the Voting Proposal
(the " Stockholders Meeting "), no other corporate
proceedings on the part of the Company are necessary to approve
this Agreement and to consummate the transactions contemplated
hereby.
12
Section 3.5 No Conflict; Required Filings
and Consents .
(a) The execution and delivery by the Company of this Agreement
do not, the execution and delivery by the Company of any instrument
required hereby to be executed and delivered by the Company at the
Closing will not, and the performance by the Company of its
agreements and obligations under this Agreement will not,
(i) conflict with or violate the Company Charter or Company
Bylaws or any Subsidiary Documents, (ii) in any material
respect, conflict with or violate any Law applicable to the Company
or any of its Subsidiaries or by which its or any of their
respective properties is bound or affected, (iii) except as
set forth in Section 3.5(a) of the Company Disclosure
Schedule, result in any breach of or constitute a default (or an
event that with notice or lapse of time or both would become a
default), or impair the Company’s or any of its
Subsidiaries’ rights or alter the rights or obligations of
any third party under, or give to any third party any rights of
termination, amendment, payment, acceleration or cancellation of,
or result in the creation of a Lien on any of the properties or
assets (including intangible assets) of the Company or any of its
Subsidiaries pursuant to, any note, bond, mortgage, indenture,
contract, agreement, lease, license, permit, franchise or other
instrument or obligation to which the Company or any of its
Subsidiaries is a party or by which the Company or any of its
Subsidiaries or its or any of their respective properties is bound
or affected, or (iv) give rise to or result in any person
having, or having the right to exercise, any pre-emptive rights,
rights of first refusal, rights to acquire or similar rights with
respect to any capital stock of the Company or any of its
Subsidiaries or any of their respective assets or properties, other
than rights to acquire Company Common Stock pursuant to outstanding
stock options.
(b) The execution and delivery by the Company of this Agreement
do not, the execution and delivery by the Company of any instrument
required hereby to be executed and delivered by the Company at the
Closing will not, and the performance of its agreements and
obligations under this Agreement by the Company will not, require
any consent, approval, order, license, authorization, registration,
declaration or permit of, or filing with or notification to, any
court, arbitrational tribunal, administrative or regulatory agency
or commission or other governmental authority or instrumentality
(whether domestic or foreign, a " Governmental Entity "),
except (i) as may be required by the Hart-Scott-Rodino
Antitrust Improvements Act of 1976, as amended (the " HSR
Act "), (ii) as may be required under any foreign
antitrust or competition Law, including Council Regulation
No. 4064/89 of the European Community, as amended (the " EC
Merger Regulation "), (iii) the filing of the Proxy
Statement (as defined in Section 6.3) with the Securities and
Exchange Commission (" SEC ") under the Exchange Act,
(iv) such consents, approvals, orders, licenses,
authorizations, registrations, declarations, permits, filings, and
notifications as may be required under applicable U.S. federal and
state or foreign securities Laws, (v) the filing of the
Certificate of Merger or other documents as required by the DGCL
and (vi) such other consents, approvals, orders,
registrations, declarations, permits, filings and notifications
which, if not obtained or made, would not reasonably be expected to
have, individually or in the aggregate, a Company Material Adverse
Effect.
13
Section 3.6 Compliance; Permits
.
(a) The Company and its Subsidiaries are and have been in
material compliance with and are not in material default or
violation of (and have not received any notice of material
non-compliance, default or violation with respect to) any Law
applicable to the Company or any of its Subsidiaries or by which
any of their respective properties is bound or affected (including,
without limitation, federal or state criminal or civil health care
Laws and the regulations promulgated pursuant to such Laws and Laws
relating to unlawful practice of medicine or other professionally
licensed activities), and to the Knowledge of the Company there has
been no such non-compliance, default or violation thereunder.
(b) The Company and its Subsidiaries hold all permits, licenses,
easements, variances, exemptions, consents, certificates,
authorizations, registrations, orders and other approvals from
Governmental Entities (including any authorizations required under
the Federal Food, Drug and Cosmetic Act of 1938, as amended (the "
FDCA ") and any regulations of the U.S. Food and Drug
Administration (the " FDA ") promulgated thereunder) that
are material to the operation of the business of the Company and
its Subsidiaries taken as a whole as currently conducted
(collectively, the " Permits "). The Permits are in full
force and effect, have not been violated in any material respect
and, to the Company’s Knowledge, no suspension, revocation or
cancellation thereof has been threatened, and there is no action,
proceeding or investigation pending or, to the Company’s
Knowledge, threatened, seeking the suspension, revocation or
cancellation of any Permits. No Permit shall cease to be effective
as a result of the consummation of the transactions contemplated by
this Agreement other than as would not reasonably be expected to
have, individually or in the aggregate, a Company Material Adverse
Effect.
Section 3.7 SEC Filings; Financial Statements .
(a) The Company has filed all forms, reports, schedules,
statements and other documents, including any exhibits thereto,
required to be filed by the Company with the SEC (collectively, the
" SEC Reports "). The SEC Reports, including all forms,
reports and documents filed by the Company with the SEC after the
date hereof and prior to the Effective Time, (i) were and, in
the case of SEC Reports filed after the date hereof, will be,
prepared in all material respects in accordance with the applicable
requirements of the Securities Act and the Exchange Act, as the
case may be, and the rules and regulations thereunder, and
(ii) did not at the time they were filed (or if amended or
superseded by a filing prior to the date of this Agreement, then on
the date of such filing), and in the case of such forms, reports
and documents filed by the Company with the SEC after the date of
this Agreement, will not as of the time they are filed, contain any
untrue statement of a material fact or omit to state a material
fact required to be stated in such SEC Reports or necessary in
order to make the statements in such SEC Reports, in light of the
circumstances under which they were and will be made, not
misleading. None of the Subsidiaries of the Company is required to
file any forms, reports, schedules, statements or other documents
with the SEC.
(b) Each of the consolidated financial statements (including, in
each case, any related notes and schedules), contained in the SEC
Reports, including any SEC Reports
14
filed after the date of this Agreement and prior
to the Effective Time, complied or will comply, as of its
respective date, in all material respects with all applicable
accounting requirements and the published rules and regulations of
the SEC with respect thereto, was or will be prepared in accordance
with U.S. generally accepted accounting principles (" GAAP
") (except as may be indicated in the notes thereto) applied on a
consistent basis throughout the periods involved and fairly
presented in all material respects or will fairly present in all
material respects the consolidated financial position of the
Company and its Subsidiaries as of the respective dates thereof and
the consolidated results of its operations and cash flows for the
periods indicated, except as otherwise explained therein and except
that any unaudited interim financial statements are subject to
normal and recurring year-end adjustments which have not been and
are not expected to be material in amount, individually or in the
aggregate. The audited balance sheet contained in the SEC Report on
Form 10-K for the fiscal year ended December 31, 2005 is
referred to herein as the " Balance Sheet ."
(c) The chief executive officer and chief financial officer of
the Company have made all certifications required by, and would be
able to make such certifications as of the date hereof and as of
the Closing Date as if required to be made as of such dates
pursuant to, Sections 302 and 906 of the Sarbanes-Oxley Act of 2002
(the " Sarbanes-Oxley Act ") and any related rules and
regulations promulgated by the SEC, and the statements contained in
any such certifications are complete and correct, and the Company
is otherwise in compliance with all applicable effective provisions
of the Sarbanes-Oxley Act and the applicable listing and corporate
governance rules of the NASDAQ Global Market.
Section 3.8 Disclosure Controls and Procedures .
Since December 31, 2005 the Company and each of its
Subsidiaries has had in place "disclosure controls and procedures"
(as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the
Exchange Act) reasonably designed and maintained to ensure that all
information (both financial and non-financial) required to be
disclosed by the Company in the reports that it files or submits to
the SEC under the Exchange Act is recorded, processed, summarized
and reported within the time periods specified in the rules and
forms of the SEC and that such information is accumulated and
communicated to the Company’s management as appropriate to
allow timely decisions regarding required disclosure and to make
the certifications of the chief executive officer and chief
financial officer of the Company required under the Exchange Act
with respect to such reports. The Company maintains internal
accounting controls sufficient to provide reasonable assurances
that (i) transactions are executed in accordance with
management’s general or specific authorizations,
(ii) transactions are recorded as necessary to permit
preparation of financial statements in conformity with generally
accepted accounting principles and to maintain accountability for
assets, (iii) access to assets is permitted only in accordance
with management’s general or specific authorization, and
(iv) the recorded accountability for assets is compared with
the existing assets at reasonable intervals and appropriate action
is taken with respect to any differences. Except as set forth in
Section 3.8 of the Company Disclosure Schedule, none of the
Company’s or its Subsidiaries’ respective records,
systems, controls, data or information are recorded, stored,
maintained, operated or otherwise wholly or partly dependent on or
held by any means (including any electronic, mechanical or
photographic process, whether computerized or not) which (including
all means of access thereto and therefrom) are not under the
exclusive ownership and direct control of the Company or its
Subsidiaries or accountants.
15
Section 3.9 Absence of Certain Changes or
Events . Since the date of the Balance Sheet and except as
disclosed in the SEC Reports filed prior to the date of this
Agreement, the Company has conducted its business in the ordinary
course of business consistent with past practice and, since the
date of the Balance Sheet, there has not occurred: (i) any
Company Material Adverse Effect; (ii) any amendments to or
changes in the Company Charter, Company Bylaws or Subsidiary
Documents; (iii) any material damage to, destruction or loss
of any asset of the Company or any of its Subsidiaries (whether or
not covered by insurance) that could reasonably be expected to
have, individually or in aggregate, a Company Material Adverse
Effect; (iv) any change by the Company in its accounting
methods, principles or practices other than as required by GAAP or
applicable Law; (v) any revaluation by the Company of any of
its assets, including writing down the value of inventory or
writing off notes or accounts receivable other than in the ordinary
course of business consistent with past practice, in terms of both
frequency and amount, and in any event in excess of $500,000;
(vi) any sale of a material amount of assets (tangible or
intangible) of the Company or any of its Subsidiaries;
(vii) any recalls, field notifications, field corrections or
safety alerts material to the operations of the Company or
reportable to the FDA, or product complaints material to the
operations of the Company, with respect to products manufactured by
or on behalf of the Company or any of its Subsidiaries;
(viii) abandoning, permitting to lapse, or otherwise disposing
of material Intellectual Property; or (ix) any other action or
event that would have required the consent of Parent pursuant to
Section 5.1 had such action or event occurred after the date
of this Agreement.
Section 3.10 No Undisclosed Liabilities .
(a) Except as reflected in the Balance Sheet or the SEC Reports,
neither the Company nor any of its Subsidiaries has any liabilities
(absolute, accrued, contingent or otherwise) which are required by
GAAP to be set forth on a consolidated balance sheet of the Company
and its consolidated subsidiaries or in the notes thereto, other
than (i) any liabilities and obligations incurred since the
date of the Balance Sheet in the ordinary course of business
consistent with past practice, (ii) any liabilities or
obligations incurred in connection with the transactions
contemplated by this Agreement and (iii) liabilities that,
individually and in the aggregate, have not had, and would not
reasonably be expected to have, a Company Material Adverse
Effect.
(b) Neither the Company nor any of its Subsidiaries is a party
to, or has any commitment to become a party to, any joint venture,
partnership agreement or any similar contract (including any
contract relating to any transaction, arrangement or relationship
between or among the Company or any of its Subsidiaries, on the one
hand, and any unconsolidated affiliate, including any structured
finance, special purpose or limited purpose entity or person, on
the other hand) where the purpose or intended effect of such
arrangement is to avoid disclosure of any material transaction
involving the Company or any of its Subsidiaries in the
Company’s consolidated financial statements.
16
Section 3.11 Absence of Litigation;
Investigations . Except as disclosed in the SEC Reports filed
and publicly available on the SEC’s EDGAR database prior to
the date of this Agreement (the " Filed SEC Documents ") or
in Section 3.11 of the Company Disclosure Schedule, there are
no material claims, actions, suits, proceedings, governmental
investigations, inquiries or subpoenas (other than arising from or
relating to the Merger or any of the other transactions
contemplated by this Agreement), (a) pending against the
Company or any of its Subsidiaries or any of their respective
properties or assets, (b) to the Company’s Knowledge,
threatened against the Company or any of its Subsidiaries, or any
of their respective properties or assets or (c) whether filed
or threatened, that have been settled or compromised by the Company
or any Subsidiary within the three (3) years prior to the date
of this Agreement and at the time of such settlement or compromise
were material. Neither the Company nor any Subsidiary of the
Company is subject to any outstanding order, writ, injunction or
decree that would reasonably be expected to be material or would
reasonably be expected to prevent or delay the consummation of the
transactions contemplated by this Agreement. There has not been nor
are there currently any internal investigations or inquiries being
conducted by the Company, the Company Board (or any committee
thereof) or any third party at the request of any of the foregoing
concerning any financial, accounting, tax, conflict of interest,
self-dealing, fraudulent or deceptive conduct or other misfeasance
or malfeasance issues.
Section 3.12 Agreements, Contracts and Commitments
.
(a) All of the Material Contracts (as defined below) that are
required to be described in the SEC Reports (or to be filed as
exhibits thereto) are so described or filed and are in full force
and effect. Section 3.12(a) of the Company Disclosure Schedule
contains a complete and accurate list of, and true and complete
copies have been delivered or made available to Parent with respect
to, all Material Contracts in effect as of the date hereof other
than the Material Contracts which are listed as an exhibit to the
Company’s most recent annual report on Form 10-K or a
subsequent quarterly report on Form 10-Q. " Material
Contracts " shall mean any note, bond, mortgage, indenture,
guarantee, other evidence of indebtedness, lease, license,
contract, agreement or other instrument or obligation to which the
Company or any of its Subsidiaries is a party or by which any of
them or any of their Assets are bound, and which either
(i) has a remaining term of more than one year from the date
hereof and (A) cannot be unilaterally terminated by the
Company at any time, without material penalty, within thirty
(30) days of providing notice of termination, and
(B) involves the payment or receipt of money in excess of
$500,000 during its remaining term, (ii) involves the payment
or receipt of money in excess of $500,000 during the remaining term
of such instrument or (iii) contains covenants limiting the
freedom of the Company or any of its Subsidiaries to sell any
products or services of or to any other person, engage in any line
of business or compete with any person or operate at any
location.
(b) As of the date of this Agreement, (i) there is no
breach or violation of or default by the Company or any of its
Subsidiaries under any of the Material Contracts, except such
breaches, violations and defaults as have been waived, and
(ii) no event has occurred with respect to the Company or any
of its Subsidiaries which, with notice
17
lapse of time or both, would constitute a breach,
violation or default, or give rise to a right of termination,
modification, cancellation, foreclosure, imposition of a Lien,
prepayment or acceleration under any of the Material Contracts,
which breach, violation or default referred to in clauses
(i) or (ii), individually or in the aggregate, would
reasonably be expected to have a Company Material Adverse
Effect.
Section 3.13 Employee Benefit Plans, Options and
Employment Agreements .
(a) Section 3.13(a) of the Company Disclosure Schedule sets
forth a complete and accurate list of all Employee Benefit Plans
maintained, or contributed to by the Company, any of the
Company’s Subsidiaries or any of their respective ERISA
Affiliates or to which the Company, any of the Company’s
Subsidiaries or any of their respective ERISA Affiliates is
obligated to contribute, or under which any of them has or may have
any liability for premiums or benefits (collectively, the "
Company Employee Plans "). For purposes of this Agreement,
the following terms shall have the following meanings: (i) "
Employee Benefit Plan " means any "employee pension benefit
plan" (as defined in Section 3(2) of ERISA), any "employee
welfare benefit plan" (as defined in Section 3(1) of ERISA),
and any other written or oral plan, agreement or arrangement
involving material compensation, including insurance coverage,
severance benefits, disability benefits, deferred compensation,
bonuses, stock options, stock purchase, phantom stock, stock
appreciation or other forms of fringe benefits, perquisites,
incentive compensation or post-retirement compensation and all
employment, change in control, severance or similar agreements,
written or otherwise, for the benefit of, or relating to, any
current or former employee, officer or director of the Company or
any of its Subsidiaries, as applicable, or any ERISA Affiliate;
(ii) " ERISA " means the Employee Retirement Income
Security Act of 1974, as amended; and (iii) " ERISA
Affiliate " means any entity which is, or at any applicable
time was, a member of (A) a controlled group of corporations
(as defined in Section 414(b) of the Code), (B) a group
of trades or businesses under common control (as defined in
Section 414(c) of the Code) or (C) an affiliated service
group (as defined under Section 414(m) of the Code or the
regulations under Section 414(o) of the Code), any of which
includes or included the Company or a Subsidiary.
(b) With respect to each Company Employee Plan, the Company has
delivered to Parent complete and accurate copies of (i) such
Company Employee Plan (or a written summary of any unwritten plan)
together with all amendments, (ii) in the case of any plan for
which Forms 5500 are required to be filed, the most recent annual
report (Form 5500) with schedules attached, (iii) in the case
of any plan that is intended to be qualified under
Section 401(a) of the Code, the most recent determination
letter from the Internal Revenue Service, (iv) each trust
agreement, group annuity contract, administration and similar
material agreements, investment management or investment advisory
agreements, (v) the most recent summary plan descriptions and
employee handbook, or other similar material employee
communications relating to employee benefits matters, (vi) all
personnel, payroll and employment manuals and policies, and
(vii) the most recent financial statements for each Company
Employee Plan that is funded.
18
(c) Each Company Employee Plan has been
administered in all material respects in accordance with ERISA, the
Code and all other applicable Laws and the regulations thereunder
and in accordance with its terms and each of the Company, the
Company’s Subsidiaries and their respective ERISA Affiliates
have in all material respects met their obligations with respect to
each Company Employee Plan and have timely made (or timely will
make) all required contributions thereto. All filings and reports
as to each Company Employee Plan required to have been submitted to
the Internal Revenue Service or to the United States Department of
Labor have been timely submitted. With respect to the Company
Employee Plans, no event has occurred, and, to the Company’s
Knowledge, there exists no condition or set of circumstances in
connection with which the Company, any of its Subsidiaries or any
plan participant could be subject to any material tax, fine, lien,
penalty or liability under ERISA, the Code or any other applicable
Law, nor will the negotiation or consummation of the transactions
contemplated by this Agreement give rise to any such material
liability.
(d) With respect to the Company Employee Plans, there are no
material benefit obligations for which contributions have not been
made or properly accrued and there are no benefit obligations which
have not been accounted for by reserves, or otherwise properly
footnoted in accordance with the requirements of GAAP, on the
financial statements of the Company. The assets of each Company
Employee Plan which is funded are reported at their fair market
value on the books and records of such Employee Benefit Plan.
(e) No Company Employee Plan has assets that include securities
issued by the Company, any of the Company’s Subsidiaries or
any of their ERISA Affiliates.
(f) All the Company Employee Plans that are intended to be
qualified under Section 401(a) of the Code (each, a "
Qualified Plan ") have received determination, opinion or
advisory letters from the Internal Revenue Service to the effect
that such Company Employee Plans are qualified and the plans and
trusts related thereto are exempt from federal income taxes under
Sections 401(a) and 501(a), respectively, of the Code, or the
Company has remaining a period of time under applicable U.S.
Department of the Treasury regulations or Internal Revenue Service
pronouncements in which to apply for such a letter and to make any
amendments necessary to obtain a favorable determination as to the
qualified status of each such Qualified Plan. To the
Company’s Knowledge, no such determination, opinion or
advisory letter has been revoked and revocation has not been
threatened, and no such Employee Benefit Plan has been amended or
operated since the date of its most recent determination letter or
application therefor in any respect, and no act or omission has
occurred, that would reasonably be expected to adversely affect its
qualification or materially increase its cost. There has been no
termination, partial termination or discontinuance of contributions
to any Qualified Plan that will result in material liability to the
Company. Each Company Employee Plan which is required to satisfy
Section 401(k)(3) or Section 401(m)(2) of the Code has
been tested for compliance with, and satisfies in all material
respects the requirements of Section 401(k)(3) and
Section 401(m)(2) of the Code, as the case may be, for each
plan year ending prior to the Closing Date for which testing is
required to be completed.
19
(g) Neither the Company, any of the
Company’s Subsidiaries nor any of their respective ERISA
Affiliates has (i) ever maintained a Company Employee Plan
which was ever subject to Section 412 of the Code or Title IV
of ERISA or (ii) ever been obligated to contribute to a
"multiemployer plan" (as defined in Section 4001(a)(3) of
ERISA). No Company Employee Plan is funded by, associated with or
related to a "voluntary employees’ beneficiary association"
within the meaning of Section 501(c)(9) of the
Code.
(h) To the extent permitted by applicable Law, each Company
Employee Plan is amendable and terminable unilaterally by the
Company and any of the Company’s Subsidiaries party thereto
or covered thereby at any time without material liability to the
Company or any of its Subsidiaries as a result thereof, other than
for benefits accrued as of the date of such amendment or
termination and routine administrative costs.
(i) Other than as required under Section 601 et seq. of
ERISA, none of the Company Employee Plans promises or provides
health or other welfare benefits (excluding normal claims for
benefits under the Company’s group life insurance, accidental
death and dismemberment insurance and disability plans and
policies) or coverage to any person following retirement or other
termination of employment.
(j) There is no action, suit, proceeding, claim, arbitration,
audit or investigation pending or, to the Company’s
Knowledge, threatened, with respect to any Company Employee Plan,
other than claims for benefits in the ordinary course. No Company
Employee Plan is or within the last three calendar years has been
the subject of, or has received notice that it is the subject of,
examination by a government agency or a participant in a government
sponsored amnesty, voluntary compliance or similar program.
(k) To the Company’s Knowledge, each individual who has
received compensation for the performance of services on behalf of
the Company, any of the Company’s Subsidiaries or any of
their respective ERISA Affiliates has been properly classified as
an employee or independent contractor in accordance with applicable
Law.
(l) Each Company Employee Plan maintained or covering employees
outside the United States, and the books and records thereof, is in
material compliance with all applicable Laws of each applicable
jurisdiction. Section 3.13(l) of the Company Disclosure
Schedule lists each country in which the Company or any of its
Subsidiaries or affiliates has operations and the number of
employees in each such country.
(m) Section 3.13(m) of the Company Disclosure Schedule sets
forth a true, complete and correct list of (i) all employment
agreements with employees of the Company or any of its
Subsidiaries; (ii) all employees or former employees of the
Company or any of its Subsidiaries who have executed a
non-competition agreement with the Company or any of its
Subsidiaries; (iii) all severance agreements, programs and
policies of the Company or any of its Subsidiaries with or relating
to its employees, excluding programs and policies required to be
maintained by Law; and (iv) all plans, programs, agreements
and other arrangements of the Company or any of its Subsidiaries
pursuant to which payments
20
(or acceleration of benefits or vesting of
options or lapse of repurchase rights) may be required upon, or may
become payable directly or indirectly as a result of or in
connection with, the negotiation or consummation of the
transactions contemplated by, or the execution of, this Agreement.
True, complete and correct copies of each of the foregoing
agreements to which any employee of the Company is a party have
been made available to Parent.
(n) All contributions required to be made with respect to any
Company Employee Plan on or prior to the Effective Time have been
or will be timely made or are reflected on the Balance Sheet. There
are no pending, or, to the Company’s Knowledge, threatened or
reasonably anticipated claims by or on behalf of any Plan, by any
employee or beneficiary covered under any such Company Employee
Plan, or otherwise involving any such Plan (other than routine
claims for benefits).
(o) Except as set forth as Section 3.13(o) of the Company
Disclosure Schedule, the negotiation or consummation of the
transactions contemplated by this Agreement will not, either alone
or in combination with another event, (i) entitle any current
or former employee or officer of the Company or any Subsidiary of
the Company to severance pay, or any other payment from the Company
or any of its Subsidiaries or (ii) accelerate the time of
payment or vesting, a lapse of repurchase rights or increase the
amount of compensation due any such employee or officer. There is
no Company Employee Plan or other contract, agreement, plan or
arrangement that, individually or collectively, could give rise to
the payment of any amount that would not be deductible pursuant to
Sections 280G (determined without regard to Section 280G(b)(4)
of the Code) or 162(m) of the Code.
(p) Each Company Employee Plan that is a "nonqualified deferred
compensation plan" (as defined in Section 409A(d)(1) of the
Code) has been operated since January 1, 2005 in good faith
compliance with Section 409A of the Code and IRS Notice
2005-1. No Company Employee Plan that is a "nonqualified deferred
compensation plan" has been materially modified (as determined
under Notice 2005-1) after October 3, 2004. No award granted
under any of the Company Stock Plans is subject to
Section 409A of the Code.
Section 3.14 Labor Matters .
(a) The Company and each of its Subsidiaries are and have been
in compliance in all material respects with all applicable Laws
respecting employment and employment practices, including, without
limitation, all Laws respecting terms and conditions of employment,
health and safety, wages and hours, child labor, immigration,
employment discrimination, disability rights or benefits, equal
opportunity, plant closures and layoffs, affirmative action,
workers’ compensation, labor relations, employee leave issues
and unemployment insurance. Neither the Company nor any of its
Subsidiaries is delinquent in payments to any current or former
employees for any services or amounts required to be reimbursed or
otherwise paid. Neither the Company nor any of its Subsidiaries is
a party to, or otherwise bound by, any order, writ, judgment,
injunction, decree, stipulation, determination or award relating to
employees or employment practices entered by or with any
Governmental Entity.
21
(b) All personnel policies, rules and procedures
applicable to employees of the Company and/or any of its
Subsidiaries are in writing. There are no written personnel
manuals, handbooks, policies, rules or procedures applicable to
employees of the Company and/or any of its Subsidiaries, other than
those set forth in Section 3.14(b) of the Company Disclosure
Schedule, true and complete copies of which have heretofore been
provided to Parent.
(c) Neither the Company nor any of its Subsidiaries has received
(i) notice of any unfair labor practice charge or complaint
pending or threatened before the National Labor Relations Board or
any other Governmental Entity against them, (ii) notice of any
complaints, grievances or arbitrations arising out of any
collective bargaining agreement or any other complaints, grievances
or arbitration proceedings against them, (iii) notice of any
charge or complaint with respect to or relating to them pending
before the Equal Employment Opportunity Commission or any other
Governmental Entity responsible for the prevention of unlawful
employment practices, (iv) notice of the intent of any
Governmental Entity responsible for the enforcement of labor,
employment, wages and hours of work, child labor, immigration, or
occupational safety and health Laws to conduct an investigation
with respect to or relating to them or notice that such
investigation is in progress, or (v) notice of any complaint,
lawsuit or other proceeding pending or threatened in any forum by
or on behalf of any present or former employees, any applicant for
employment or classes of the foregoing alleging breach of any
express or implied contract of employment, any applicable Law
governing employment or the termination thereof or other
discriminatory, wrongful or tortious conduct in connection with the
employment relationship.
(d) The Company and each of its Subsidiaries has good labor
relations, and the Company, each of its Subsidiaries, and their
respective employees, agents or representatives have not committed
any material unfair labor practice as defined in the National Labor
Relations Act. Neither the Company nor any of its Subsidiaries is a
party to, bound by or subject to (and none of the Company’s
and/or any of its Subsidiaries’ properties or assets is bound
by or subject to) any labor agreement, collective bargaining
agreement, work rules or practices, or any other labor-related
agreements or arrangements with any labor union, labor
organization, trade union or works council. There are no labor
agreements, collective bargaining agreements, work rules or
practices, or any other labor-related agreements or arrangements
that pertain to any of the employees of the Company and/or any of
its Subsidiaries, and no employees of the Company and/or any of its
Subsidiaries are represented by any labor union, labor
organization, trade union or works council with respect to their
employment with the Company and/or any of its Subsidiaries.
(e) To the Company’s Knowledge, there are no current labor
union organizing activities with respect to any employees of the
Company and/or any of its Subsidiaries. No labor union, labor
organization, trade union, works council, or group of employees of
the Company and/or any of its Subsidiaries has made a pending
demand for
22
recognition or certification, and there are no
representation or certification proceedings or petitions seeking a
representation proceeding presently pending or threatened in
writing to be brought or filed with the National Labor Relations
Board or any other labor relations tribunal or authority. To the
Company’s Knowledge, there are no labor disputes, strikes,
slowdowns, work stoppages, lockouts, or threats thereof, against or
affecting the Company or any of its Subsidiaries, nor has there
been any of the foregoing during the 5-year period before the date
of this Agreement.
(f) No employee of the Company or any of its Subsidiaries
(i) to the Company’s Knowledge is in violation of any
term of any patent disclosure agreement, non-competition agreement,
or any restrictive covenant to a former employer relating to the
right of any such employee to be employed by the Company or any of
its Subsidiaries because of the nature of the business conducted or
presently proposed to be conducted by the Company or any of its
Subsidiaries or relating to the use of trade secrets or proprietary
information of others, or (ii) in the case of any key employee
or group of key employees, has given notice as of the date of this
Agreement to the Company or any of its Subsidiaries that such
employee or any employee in a group of key employees intends to
terminate his or her employment with the Company or any of its
Subsidiaries, whether on account of the transactions contemplated
by this Agreement or for any other reason.
(g) The Company and each of its Subsidiaries are and have been
in compliance with all notice and other requirements under the
Worker Adjustment and Retraining Notification Act of 1988, as
amended (the " WARN Act "), and any similar foreign, state
or local Law relating to plant closings and layoffs. Neither the
Company nor any of its Subsidiaries is currently engaged in any
layoffs or employment terminations sufficient in number to trigger
application of the WARN Act or any similar state, local or foreign
Law. Section 3.14(g) of the Company Disclosure Schedule
contains a true and complete list of the names and the sites of
employment or facilities of those individuals who suffered an
"employment loss" (as defined in the WARN Act) at any site of
employment or facility of the Company or any of its Subsidiaries
during the 90-day period prior to the date of this Agreement.
Section 3.14(g) of the Company Disclosure Schedule shall be
updated immediately prior to the Closing with respect to the 90-day
period prior to the Closing.
(h) The execution of this Agreement and the consummation of the
transactions contemplated by this Agreement will not, either alone
or in combination with any other event, result in any material
breach or other violation of any collective bargaining agreement,
employment agreement, consulting agreement or any other
labor-related agreement to which the Company and/or any of its
Subsidiaries is a party.
Section 3.15 Properties; Encumbrances .
(a) Each of the Company and each of its Subsidiaries has good
and valid title to, or a valid leasehold interest in, all the
properties and assets which it purports to own or lease (real,
tangible, personal and mixed), including all the properties and
assets reflected in the Balance Sheet (except for personal property
sold since the date of the Balance Sheet in the ordinary course of
business consistent with past practice). All properties and assets
reflected in the Balance Sheet are free and clear of all Liens,
except for Liens reflected on the Balance Sheet and Li
|